Institutional investors hold a majority ownership of MYGN through the 119.31% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2016, these large investors purchased a net $55.6 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RUSSELL INVESTMENT MANAGEMENT LL... Bought 891.7 Thousand shares of Myriad Genetics Inc
MORGAN STANLEY & CO. LLC Bought 620.6 Thousand shares of Myriad Genetics Inc